“I thank everyone involved who made this weekend happen. It has helped me so very much in all aspects. Being newly diagnosed, it has been a blessing to talk to other families.” CAMP TWINKLETOES PROGRAM 2017 Camp Twinkletoes is anread more..
One in 1,000 children in Australia suffer from juvenile arthritis. More than 30 of them will be at a New South Wales Central Coast camp later this month. Camp Footloose, an initiative run by Arthritis & Osteoporosis NSW (AONSW), gives children diagnosedread more..
We’re challenging everyone to walk 10,000 steps per day for seven days over Arthritis Awareness Week (29 May to 4 June 2016). Help us raise awareness for this often invisible disease! Read more
Jannine gives her perspective on a recent study that claims paracetamol is not clinically effective in treating osteoarthritic pain. Read more
Non-Excutive Director Arthritis & Osteoporosis NSW Arthritis & Osteoporosis NSW is a not for profit working to support people living with Arthritis and Osteoporosis across New South Wales. Nearing our 50th year, we are a non-government health charity that aims toread more..
Some handy tips and advice on being medicine wise over the Christmas holidays. Read more
From 1 January 2016, a number of over-the-counter medications including osteo-paracetamol will be removed from the Pharmaceutical Benefits Scheme. This means vulnerable groups such as pensioners could end up paying three times more for their medication. Last Tuesday, Kate Creedonread more..
Dr Amy Norman is far from the typical impression of someone with arthritis. The 25-year-old chiropractor had no clue why she struggled to do things like squeeze shampoo out of a bottle to wash her hair, pick up a penread more..
In the morning, a typical teenager might have bacon and eggs with toast or a bowl of cereal with milk, but not Alyssa who will also have up to six different types of drugs with breakfast before going to school.read more..
by Franca Marine, National Policy & Government Relations Manager, Arthritis Australia The advent of biosimilars heralds a new era in biologic therapy for auto-immune forms of arthritis. But government moves to drive the uptake of biosimilars to achieve budget savings have raisedread more..